A Phase IV Study of the Onset and Maintenance of the Antiplatelet Effect of Ticagrelor Compared With Clopidogrel in Chinese Patients With ACS

Summary

The purpose of this study is to test the hypothesis that the onset of the antiplatelet effect of ticagrelor is more rapid and greater than clopidogrel in Chinese patients with ACS.

Timeline

Start

2013-05

Primary completion

2014-03

Completion

2014-03

Outcome

Met primary endpoint

registry analysis (superiority or other test); Ticagrelor vs Clopidogrel; p = 0.0021; Wilcoxon (Mann-Whitney); note: not adjusted for multiple comparisons. NCT01864005 ↗

Drugs

Indications